Ticker Attention Investors: Beware of fraudulent Calls, SMS, Emails, WhatsApp & Telegram messages assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Elevate App only from Google Play Store or Apple App Store or login to Elevate Web portal. Click Here to know more.

ABC Home
Loans
Investments Alternative Investments
Insurance
Payments
Download ABCD

Experience finance made simple on the new ABCD app!

Scan to Download the App

Playstore
Appstore
1800-270-7000

Aditya Birla Money Limited

Search
Recent Searches

Aditya Birla Money Limited

J B Chemicals & Pharmaceuticals Ltd

BUY SELL

Symbol : JBCHEPHARM | BSE Code : 506943 | Sector : PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

1,988.9010.20 (0.52%)
17-Feb-2026 | 12:00
Loading

Market Cap (₹ Cr.)

31,927.32
Today’s High / Low
1,995.00
1,963.30
52 Week High / Low
2,008.00
1,385.75
1,988.2510.40 (0.53%)
17-Feb-2026 | 12:00
Loading

Market Cap (₹ Cr.)

31,916.89
Today’s High / Low
1,992.90
1,965.15
52 Week High / Low
2,007.50
1,303.00
1,988.9010.20 (0.52%)
17-Feb-2026 | 12:00

Turnover (₹ Cr.)

35,939,113,260.00
Today’s High / Low
61,198
60,632.00
1,988.9010.20 (0.52%)
17-Feb-2026 | 12:00

Turnover (₹ Cr.)

12,881,409,180.00
Today’s High / Low
58
35.20
OVERVIEW
  • Open
  • 1,989.00
  • Prev. Close
  • 1,978.70
  • High
  • 1,995.00
  • Low
  • 1,963.30
  • Market Cap (₹ Cr.)
  • 31,927.32
  • 52 Week High
  • 2,008.00
  • 52 Week Low
  • 1,385.75
  • Traded Volume (Lacs)
  • 326,078
  • Traded Value (Cr)
  • Dividend Yield
  • 0.76
  • Face Value
  • 1.00
  • EPS
  • 45.31
  • P/E
  • 43.88
  • Beta (1 year)
  • 1.02
OVERVIEW
  • Open
  • 1,980.75
  • Prev. Close
  • 1,977.85
  • High
  • 1,992.90
  • Low
  • 1,965.15
  • Market Cap (₹ Cr.)
  • 31,916.89
  • 52 Week High
  • 2,007.50
  • 52 Week Low
  • 1,303.00
  • Traded Volume (Lacs)
  • 2,132
  • Traded Value (Cr)
  • Dividend Yield
  • 0.76
  • Face Value
  • 1.00
  • EPS
  • 45.31
  • P/E
  • 43.88
  • Beta (1 year)
OVERVIEW
  • Open
  • 60,910.00
  • Prev. Close
  • 60,968.80
  • High
  • 61,198
  • Low
  • 60,632.00
  • Strike Price
  • 0.00
  • Open Interest(Nos.)
  • 1,431,660.00
  • OI Change %
  • 2.07
  • Volume(Lacs)
  • 2.07
  • Lot Size
  • 30.00
  • Average Price
  • 60,968.33
  • OI Difference
  • 28,980.00
  • Previous OI
  • 1,402,680.00
OVERVIEW
  • Open
  • 55.00
  • Prev. Close
  • 64.50
  • High
  • 58
  • Low
  • 35.20
  • Strike Price
  • 58,400.00
  • Open Interest(Nos.)
  • 84,690.00
  • OI Change %
  • 41.01
  • Volume(Lacs)
  • 41.01
  • Lot Size
  • 30.00
  • Average Price
  • 44.52
  • OI Difference
  • 24,630.00
  • Previous OI
  • 60,060.00
LAST 5 DAYS

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY -11.09%

  • 18/02/2026 BSE
    10.40(0.53)
    Close Price: ₹ 1,988.25
    Volume: 2,132.00

    17-Feb-2026

  • 18/02/2026 BSE
    85.15(4.50)
    Close Price: ₹ 1,977.85
    Volume: 88,530.00

    16-Feb-2026

  • 18/02/2026 BSE
    -12.05(-0.63)
    Close Price: ₹ 1,892.70
    Volume: 3,964.00

    13-Feb-2026

  • 18/02/2026 BSE
    7.85(0.41)
    Close Price: ₹ 1,904.75
    Volume: 7,580.00

    12-Feb-2026

  • 18/02/2026 BSE
    -26.65(-1.39)
    Close Price: ₹ 1,896.90
    Volume: 3,977.00

    11-Feb-2026

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY -11.09%

  • Stock Absolute
  • 3.36
  • 3.10
  • 20.90
  • 102.32
  • 239.12
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • -0.98
  • 0.25
  • 9.81
  • 36.80
  • 61.40
NEWS

Volumes spurt at C.E. Info Systems Ltd counter

16-Feb-2026

No Data Available

J B Chemicals & Pharmaceuticals Ltd, Natco Pharma Ltd, Ambuja Cements Ltd, RHI Magnesita India Ltd are among the other stocks to see a surge in volumes on BSE today, 16 February 2026.

C.E. Info Systems Ltd notched up volume of 1.52 lakh shares by 10:46 IST on BSE, a 53.98 fold spurt over two-week average daily volume of 2820 shares. The stock slipped 5.66% to Rs.1,165.00. Volumes stood at 6144 shares in the last session.

J B Chemicals & Pharmaceuticals Ltd saw volume of 76141 shares by 10:46 IST on BSE, a 23.01 fold spurt over two-week average daily volume of 3308 shares. The stock increased 5.55% to Rs.1,997.80. Volumes stood at 3964 shares in the last session.

Natco Pharma Ltd witnessed volume of 6.56 lakh shares by 10:46 IST on BSE, a 14.9 times surge over two-week average daily volume of 44074 shares. The stock increased 11.41% to Rs.915.90. Volumes stood at 82829 shares in the last session.

Ambuja Cements Ltd recorded volume of 9.85 lakh shares by 10:46 IST on BSE, a 12.57 times surge over two-week average daily volume of 78368 shares. The stock gained 0.12% to Rs.519.90. Volumes stood at 2.05 lakh shares in the last session.

RHI Magnesita India Ltd saw volume of 56167 shares by 10:46 IST on BSE, a 9.65 fold spurt over two-week average daily volume of 5821 shares. The stock increased 7.37% to Rs.469.30. Volumes stood at 3035 shares in the last session.

16
Feb

Volumes spurt at C.E. Info Systems Ltd counter



06
Feb

Board of J B Chemicals & Pharmaceuticals recommends interim dividend



05
Feb

J B Chemicals & Pharmaceuticals appoints Kaushal Solanki as CFO



FINANCIAL DATA
Balance PROFIT & LOSS QUARTERLY RESULTS (In CR.) SHAREHOLDING PATTERN

In Cr.

Mar 2025Mar 2024Mar 2023
SOURCES OF FUNDS :   
Share Capital 15.5715.5215.48
Reserves Total 3,361.632,870.742,426.98
Equity Share Warrants0.000.000.00
Equity Application Money0.000.000.03
Read More
Mar 2025Mar 2024Mar 2023
INCOME :   
Sales Turnover 3,722.923,298.642,884.16
Excise Duty0.000.000.00
Net Sales3,722.923,298.642,884.16
Other Income 34.7434.678.65
Read More
ParticularsDec 2025Sep 2025Jun 2025
Gross Sales 990.911022.651039.90
Excise Duty 000
Net Sales 990.911022.651039.90
Other Operating Income 000
Other Income  16.8914.2513.90
Read More
Category No. Of Shares Percentage (%)
Total Foreign 24202772 15.09
Total Institutions 36434526 22.71
Total Govt Holding 728 0.00
Total Non Promoter Corporate Holding 1208213 0.75
Total Promoters 78265402 48.78
Total Public & others 20,323,415.00 12.66
Total 100.00 100.00
Read More
CORPORATE ACTIONS
BONUS SPLIT DIVIDEND RIGHTS BOOK CLOSURE
Read More
Record Date Ex-Bonus Date Ratio
30-10-1998 05-10-1998 1:1
Read More
Record Date Split Date Face Value Before Face Value After
18-09-2023 18-09-2023 2 1
12-04-2005 05-04-2005 10 2
Read More
ANNOUNCEMENT DATE EX DIVIDEND DATE DIVIDEND (%) DIVIDEND TYPE
05-02-2026 11-02-2026 1270 Interim
14-05-2025 30-07-2025 700 Final
04-02-2025 07-02-2025 850 Interim
17-05-2024 14-08-2024 675 Final
06-02-2024 16-02-2024 550 Interim
PREMIUM (₹) RATIO RECORD DATE EX RIGHTS DATE
nodata
No Data Available!!!
Read More
Read More
FROM DATE EX TO DATE AGENDA
31-03-2026 NA Declaration of interim dividen...
11-02-2026 NA Rs.12.7000 pershare(1270%)Inte...
11-02-2026 NA 1270% Interim Dividend
05-02-2026 NA JB Chemicals & Pharmaceuticals...
03-02-2026 NA All market participants are he...
COMPANY INFO

J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs). The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95. Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales. JBC has its subsidiaries namely Lekar Healthcare Ltd and J.B Life Science Overseas Ltd.

JBC had a tie-up with Justesa Imagen, Spain, to manufacture and market radio diagnostics under the Trazograf brand name. JBC has also diversified into high-growth agro-based products by acquiring McDa Agro (MAL). The products manufactured by MAL complement fertilisers and increase crop productivity. It has entered into a MoU with GNFC to distribute these products locally. The pharmaceutical divisions of Ifiunik Pharmaceuticals and Unique Pharmaceutical Laboratories has been merged into the company with effect from April 2000.

Unique Chemicals (A Division of the company) manufacturing and marketing Bulk Drugs has been awarded Certificate of Suitability to Europeon Pharmacopoeia Monograph for Nifedipine EP from Europeon Directorate for the Quality Medicines.

In Feb. 2002 the company has achieved another break through in its major R & D Activity - Invention biologically active molecules - New Chemical Entity. In 2001-02 the company introduced 3 products Reducin XX and two in the Cholesterol reducing segment i.e., Ifistatin and Vasolip. The company has launched five new products during the year 2003-04 in the global markets to widen its product portfolio. During 2004-05, the company launched new prod

Read More
Get Free Demat Account